ArticleBMC cancer2025

Enhanced tumor suppression in patient-derived temozolomide-resistant glioblastoma cells using a combination treatment of Olaparib and FK866.

Xiaowei Sha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.